Kevin Patrick Lonabaugh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Shenandoah UniversityPharmD, 2010
Publications & Presentations
PubMed
- 1 citationsReal world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James
Pharmacotherapy. 2024-03-01 - 4 citationsAnalysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.Amber James, Galvin Li, Rhonda List, Kevin Lonabaugh, Aaron D Smith
Pediatric Pulmonology. 2024-03-01 - 1 citationsThe impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis.A M Mehta, I Lee, G Li, M K Jones, L Hanson
Allergy, Asthma, and Clinical Immunology. 2023-07-31
Office
1204 West Main St
Charlottesville, VA 22908Phone+1 434-297-5500
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
